Clinical Trial Update: PD-1 Inhibitor Therapy Versus Radiotherapy in MPR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy (HNC-SYSU-006) [Phase 2]

View source ↗

Summary

This phase 2 clinical trial compares PD-1 inhibitor therapy to radiotherapy in locally advanced head and neck squamous cell carcinoma patients who achieved majo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• PD-1 inhibitor therapy

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: HNSCC, PD-1 | Phase 2 | Status: NOT_YET_RECRUITING